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In this study we aimed to identify the physiological roles of G protein-coupled receptor 84 (GPR84)
in adipose tissue, together with medium-chain fatty acids (MCFAs), the speciﬁc ligands for GPR84.
In mice, high-fat diet up-regulated GPR84 expression in fat pads. In 3T3-L1 adipocytes, co-culture
with a macrophage cell line, RAW264, or TNFa remarkably enhanced GPR84 expression. In the
presence of TNFa, MCFAs down-regulated adiponectin mRNA expression in 3T3-L1 adipocytes.
Taken together, our results suggest that GPR84 emerges in adipocytes in response to TNFa from
inﬁltrating macrophages and exacerbates the vicious cycle between adiposity and diabesity.
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
In the last decade, free fatty acids (FFAs) have been demon-
strated to act as ligands of several G protein-coupled receptors
(GPCRs), i.e., GPR40, GPR41, GPR43, GPR84, and GPR120 [1–4].
These fatty acid receptors are suggested to take part in the regula-
tion of energy homeostasis including insulin secretion (GPR40),
GLP-1 secretion (GPR120), and leptin regulation (GPR40, 43). Con-
trary to other FFA-GPCRs, GPR84 is a very exceptional one in that it
is exclusively expressed in bone marrow, spleen, lymph nodes, and
thymus of mice, and because its function proposed up to now is not
associated with energy homeostasis [5]. RT-PCR analyses have
demonstrated that GPR84 is eminently present in leukocytes or
RAW 264.7 cells, but in low abundance in both human and murine
adipose tissue and in 3T3-L1 adipocytes [6,7]. So far, functional
analyses have indicated that GPR84 mediates the involvement ofchemical Societies. Published by E
ogy, Fujita Health University
cho, Toyoake, Aichi 470-1192,
saki).medium-chain FFAs in the inﬂammatory processes provoked by
the immune system. A study using GPR84-deﬁcient mice revealed
that GPR84 has a role in the regulation of early IL-4 gene expres-
sion in activated T cells [8]. In leukocytes, the GPR84 expression
is markedly induced in monocytes/macrophages upon activation
by LPS, and MCFAs act through GPR84 to amplify the stimulation
of lipopolysaccharide (LPS)-induced IL-12 p40 production [5,9].
In CNS, microglia express GPR84 in animals suffering from endo-
toxemia or experimental autoimmune encephalomyelitis, which
suggests a role for GPR84 in the regulation of microglial- and
neuro-inﬂammatory processes [7]. Based on these ﬁndings, it is
proposed that GPR84 is expressed to play some roles predomi-
nantly in the immune system. However, the function of GPR84
exerted towards adipose tissue has not been addressed.
In the pathogenesis of insulin resistance, chronic activation of
inﬂammatory pathways plays an important role, and the macro-
phage/adipocyte inter-communication provides a key mechanism
underlying the common disease states of decreased insulin sensi-
tivity [10]. This involves the migration of macrophages into the adi-
pose tissue with subsequent switching-on of proinﬂammatory
pathways in the macrophages and secretion of cytokines from
them. These successive events promote inﬂammation andlsevier B.V. All rights reserved.
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[10,11]. Because over-nutrition causes a shift in adipocytes to
express pro-inﬂammatory genes, quite a few of which are common
to M1 macrophages [12], we hypothesized that the GPR84 in
adipocytes is involved in the inﬂammatory changes occurring to
adipocytes after reaching the status of ‘‘diabesity’’. In this paper,
we present the data showing GPR84 takes part in initiating the
insulin resistance in adipocytes under inﬂammatory circumstances.
2. Materials and methods
2.1. Cell culture
RAW264 macrophage cell line (RIKEN BioResource Center;
Tsukuba, Japan) and 3T3-L1 preadipocytes (American Type Culture
Collection, Manassas, VA, USA) were maintained in DMEM contain-
ing 10% FBS and antibiotics, and incubated at 37 C in a humidiﬁed
5% CO2/95% air atmosphere. Two days after the 3T3-L1 preadipo-
cytes had reached conﬂuence, differentiation was induced by
treating the cells with DMEM containing 0.5 mM 3-isobutyl-1-
methylxanthine (IBMX), 0.5 lg/ml dexamethasone, 5 lg/ml insulin
and 10% fetal bovine serum for 72 h, followed by another
72-h-incubation period in the same medium containing neither
IBMX nor dexamethasone. Differentiation was completed by
incubating the cells in DMEM containing 10% FBS for 7–14 days.
2.2. Expansion of adipose derived stromal cells (ADSCs) from human
omentum fat pad
Details for the human ADSC (hADSC) culture methods were pre-
viously described [13]. Brieﬂy, the stromal vascular fraction was
prepared from human omental fat pads by collagenase type I,
and passaged 5 times by using the low-serum culture method.
The expanded clone was cultured in adipogenic medium for
14 days, resulting in stored lipid droplets in 70% of the cells.
The procedure to prepare hADSCs was approved by the Ethical
Committee of Nagoya University Medical School (Approval num-
ber: 323.3) and the tissue sample was used according to the guide-
lines of the Committee.
2.3. Animals
Four-week-old male C57BL/6J mice were purchased from
Chubu Science Materials (Nagoya, Japan). The animals were housed
in a temperature-, humidity-, and light-controlled room (12-h light
and 12-h dark cycle) and allowed free access to water and chow.
Five-week-old mice were fed either the standard chow (Oriental
MF, 362 kcal/100 g, 5.4% energy as fat; Oriental Yeast; Tokyo,
Japan) or high-fat chow (D12492, 524 kcal/100 g, 60% energy as
fat; Research Diets; New Brunswick, NJ, USA) for 5 weeks (n = 10
for each group). They were fasted for 1 h (12:00–13:00) and
sacriﬁced to harvest the epididymal adipose tissue. All animal
experiments were conducted according to the guideline of Nagoya
University Committee on Animal Research (approval number:
21204).
2.4. Quantitative real-time polymerase chain reaction (qRT-PCR)
Total RNA was isolated from cultured 3T3-L1 cell, RAW264, and
hADSC cells by using a FastPure RNA Kit (Takara Bio Inc., Tokyo,
Japan). Pools of cDNA were synthesized from 0.5–2 lg of total
RNA by use of a RevarTraAce Kit (Toyobo, Tokyo, Japan).
qRT-PCR was performed with an Mx3000P Real-Time PCR System
(Stratagene; La Jolla, CA, USA) using qPCR MasterMix Plus for
SYBR Green I Low ROX (Eurogentec; Liège, Belgium). Speciﬁcprimers were designed by an online service at the Universal Probe
Library Assay Design Center (Roche Applied Science; Mannheim,
Germany) in an intron-spanning manner for all possible cases
(Supplementary data). To avoid DNA contamination during the
RNA extraction process, every sample was treated with DNase I
(Takara Bio Inc.). All primer pairs were conﬁrmed not to self-
dimerize by qRT-PCR using a non-template control. Expression lev-
els were calculated by using relative standard curves for each
mRNA of interest and housekeeping genes including 18S rRNA, b-
actin, and glyceraldehyde-3-phosphate dehydrogenase (GAPDH).
2.5. Co-culture of 3T3-L1 adipocytes and RAW264 cells
Differentiated 3T3-L1 adipocytes at day 14 after the induction
of differentiation were co-cultured with 1.0  105 RAW264 macro-
phages in transwell inserts with a 0.4-lm porous membrane
(Corning; Tokyo, Japan) to separate the adipocytes from the macro-
phages. After incubation for 24 h, the cells in the lower well (adipo-
cytes) were harvested.
2.6. Statistical analysis
Data were shown as the mean ± S.E.M. Statistical analysis was
performed by using ANOVA followed by Schéffe’s test. A P
value < 0.05 was considered to be statistically signiﬁcant.
3. Results and discussion
3.1. GPR84 mRNA was expressed in 3T3-L1 adipocytes
The 3T3-L1 cells were observed up to 21 days after the induc-
tion of differentiation, at which time the hypertrophic 3T3-L1 adi-
pocytes stored larger lipid droplets and showed mild elevation of
pro-inﬂammatory markers (data not shown). qRT-PCR analysis to
measure mRNA expression levels of the genes encoding GPR84
and FABP4 (an adipogenesis positive control) was performed on
conﬂuent pre-adipocytes during the course of adipose differentia-
tion (Fig. 1A). GPR84 mRNA expression was scarcely detected in
pre-adipocytes (0 day) but attained a clearly detectable level at
the third day after the induction, and maintained the level all
through the remainder of the 21-day course of the experiment.
GPR84 mRNA in the 3T3-L1 adipocytes was also identiﬁed by
nested PCR after the reverse transcriptase reaction (Fig. 1B). We
also conﬁrmed the fact that 3T3-L1 adipocytes did not express
GPR40 mRNA at a detectable level, which is an important ﬁnding
because GPR40 possesses binding afﬁnities for FFAs overlapping
with GPR84. RAW264 expressed GPR84 mRNA to a level of 20-fold
higher than that of 3T3-L1 adipocytes (Fig. 1C).
3.2. GPR84 mRNA expression is up-regulated in the adipose tissue from
high-fat chow (HFC)-induced obese mice
After 5 weeks’ feeding on HFC, mice gained 30% greater body
weight than those fed with standard chow (NC group, Fig. 2A).
Also, the weights of epididymal fat pads were approximately 2–3
times heavier for the HFC group than for the NC one (data not
shown). The HFC group also showed higher serum glucose and
insulin levels, which may reﬂect the appearance of insulin resis-
tance (Fig. 2B). TNFa mRNA expression in the epididymal fat pads
tended to be up-regulated in the HFC group compared with that in
the NC group. mRNA expression levels of genes encoding other
inﬂammation-associated substances such as monocyte chemoat-
tractant protein 1 (MCP-1) and the macrophage marker F4/80 were
also up-regulated in the HFC group, indicating that inﬂammatory
macrophages had inﬁltrated the adipose tissue (Fig. 2C). In brown
Fig. 1. mRNA expression levels of GPR84 and FABP4 in 3T3-L1 adipocytes. (A)
Expression levels of GPR84 and FABP4 mRNAs in the course of adipogenesis of 3T3-
L1 pre-adipocytes. The data are shown as the mean value ± S.E.M. from triplicate
assays. (B) Nested PCR to envisage GPR40 and GPR84 from cDNA pool. (C)
Comparison of mRNA expression levels of GPR84 between mouse macrophage cell
line RAW264 and 3T3-L1 adipocytes. The data are shown as mean value of 3
samples ± S.E.M.
Fig. 2. Effects of high-fat chow (HFC) on C57BL/6J mice. (A) The proﬁle of body
weight change. Closed circle, mice fed HFC (HFC group); open circle, mice fed
normal chow (NC group). (B) Blood glucose and serum insulin levels after 5 weeks’
feeding. The data are shown as the mean value ± S.E.M. Both groups consisted of 8
mice in each. (C) mRNA expression levels of the genes encoding GPR84 and other
obesity-related substances in the epidydimal fat pad sampled after 5 weeks’
feeding. Data shown as mean ± S.E.M. (HFC group, n = 8; NC group, n = 8), expressed
as the value relative to that for the NC group.⁄p < 0.05, ⁄⁄p < 0.01, ⁄⁄⁄p < 0.001,
signiﬁcant difference vs. NC group.
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GPR84 mRNA and MCP-1 mRNA (data not shown). It is noteworthy
that HFC increased GPR84 mRNA expression synchronously with
those of pro-inﬂammatory markers and the macrophage marker,
F4/80, in the hypertrophic fat pads. These ﬁndings led us to inves-
tigate whether macrophages possessed the driving force to cause
the expression of GRP84 in adipose tissues.
3.3. RAW264 induced GPR84 mRNA expression in 3T3-L1 adipocytes
The obesity-induced expression of GPR84 in the epididymal
adipose tissue does not necessarily mean that GPR84 came from
the adipocytes, because it may have been derived from the macro-
phages that had inﬁltrated into the adipose tissue. In order to spec-
ify the localization to the adipocyte, we co-cultured RAW264 and
fully differentiated 3T3-L1 adipocyte in the non-contact co-culture
system by using transwell culture supports. The mRNA expression
level of GPR84 and MCP-1 in 3T3-L1 adipocytes was enhanced
3- and 7-fold, respectively, over the control value (Fig. 3), which
ﬁnding strongly suggests that 3T3-L1 adipocytes themselves were
capable of synthesizing GPR84. These data showed the remote
control of RAW264 cells to enhance GPR84 mRNA expression level
in 3T3-L1 adipocytes, which suggests that some bioactive
substances secreted from the RAW264 cells were responsible for
the induction.
3.4. TNFa and LPS stimulated GPR84 mRNA expression in 3T3-L1
adipocytes and human ADSC adipocytes
It is a well-known fact that TNFa from M1 macrophages
mediates the inﬂammatory changes in adipose tissue [12]. We next
examined the effects of TNFa as a secretion product of
macrophages and LPS as a stimulator of immune cells on fully
differentiated 3T3-L1 adipocytes. qRT-PCR analysis showed that
6-h exposure of 3T3-L1 adipocytes to TNFa or to LPS markedlyincreased the mRNA expression levels of GPR84 in a dose-
dependent manner (Fig. 4A). TNFa at 10 ng/ml and LPS at 1 lg/
ml LPS increased the expression 200- and 60-fold, respectively.
We treated ADSC adipocytes from human omental fat pad with
10 ng/ml TNFa or 1 lg/ml LPS for 6 h (Fig. 4B). Both TNFa and
LPS at these doses signiﬁcantly enhanced the GPR84 mRNA expres-
sion level, suggesting that this phenomenon is in common to the
mammalian species. Based on these ﬁndings, we postulate that
GPR84 could serve as a speciﬁc marker for obesity-induced
inﬂammation in the adipose tissue.
Next we tested whether the TNFa–NF-jB pathway was
involved in the up-regulation of GPR84 mRNA expression level in
the 3T3-L1 adipocytes. TNFa increased IjBamRNA expression that
parallels both NF-jB activity and the duration of activating
extracellular stimulation [14] (Fig. 4C). When 3T3-L1 adipocytes
were pre-treated with an NF-jB inhibitor, 5 lM BAY11-7082 or
50 lM MG132, for 6 h before the addition of 10 ng/ml TNFa
Fig. 3. mRNA expression levels of GPR84 in 3T3-L1 adipocytes co-cultured with
RAW264 cells. After the adipogenic induction for 3 weeks, 3T3-L1 adipocytes were
co-cultured with RAW264 cells in a transwell permeable support (for details of the
co-cultures, see the text). Expression levels of GPR84 and MCP-1 mRNAs in the 3T3-
L1 adipocytes were measured. Data are shown as mean ± S.E.M. (n = 6 for each
group), expressed as the value relative to that of the negative control. ⁄p < 0.05,
⁄⁄p < 0.01, signiﬁcant difference vs. negative control.
Fig. 4. Effects of TNFa and LPS on mRNA expression levels of GPR84 and MCP-1 in
the adipose cells. (A) The fully differentiated 3T3-L1 adipocytes (21 days after the
initiation of the induction toward adipogenesis) were incubated with various
concentrations of TNFa or LPS for 6 h. (B) Fully differentiated human adipose tissue-
derived stromal cell (hADSC) adipocytes were incubated with TNFa or LPS for 6 h.
These adipocytes were obtained from human visceral fat pad, passaged 5 times in
low-serum cultures, and subjected to adipogenic induction. Fully differentiated
hADSC adipocytes were treated with 10 ng/ml TNFa or 1 lg/ml LPS for 6 h. (C) The
fully differentiated 3T3-L1 adipocytes were incubated with TNFa (10 ng/ml) for 6 h.
(A–C) Data are shown as the mean ± S.E.M. (n = 4 for each group), with the value
expressed relative to that of the negative control. ⁄p < 0.05, ⁄⁄p < 0.01, signiﬁcant
difference to the control. (D) Effects of pre-treatment with BAY11-7082 or MG132
on GRP84 and MCP-1 mRNA expression levels in 3T3-L1 adipocytes. Six hours prior
to the addition of 10 ng/ml TNFa, 3T3-L1 adipocytes were treated with 5 lM
BAY11-7082 or 50 lM MG132. Twelve hours later the cells were sampled for qRT-
PCR analysis. Data are shown as the mean ± S.E.M. (n = 4 for each group). ⁄p < 0.05,
⁄⁄p < 0.01, ⁄⁄⁄p < 0.001, signiﬁcant difference between the two groups indicated.
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up-regulation of the MCP-1 mRNA expression level, which is
known to be regulated by the TNFa–NF-jB pathway. These
NF-jB inhibitors also effectively blocked TNFa-induced up-regula-
tion of GPR84 mRNA expression level in the same manner. The
promoter analysis on mouse GPR84 gene (Chromosome
15 – NC_000081.5) using the TRANSFAC database (BIOBASE GmbH,
Wolfenbuettel, GERMANY) found two binding-motif for NF-jB,
‘GGGGAATCTC’, at 483 and 255 nt relative to the start codon
of GPR84. Although these data lacks the proof to show direct
recruitment of NF-jB to GPR84 promoter region, it is suggested
that TNFa–NF-jB pathway is pivotal for GPR84 regulation.
3.5. Adiponectin mRNA expression level was suppressed by decanoic
acid, a GPR84 ligand
The physiological effects of MCFA on GPR84 have not been well
elucidated; the only case that was already addressed is that MCFAs
amplify LPS-induced IL-12 p40 production through GPR84 in the
macrophage cell line RAW264.7 [5]. To elucidate the plausible
function of GPR84 on adipose tissue, we incubated 3T3-L1 adipo-
cytes with GPR84 ligands of the highest afﬁnity (C10 or undecanoic
acid (C11)) with/without pre-treatment of the cells with TNFa. C10
and C11 both dose-dependently augmented the inhibitory effects
of TNFa on the adiponectin mRNA expression level in 3T3-L1 adi-
pocytes, in which C10 was much more effective than C11 to exert
the inhibitory effect (Fig. 5). The mRNA expression levels of pro-
inﬂammatory cytokines, i.e., MCP-1, PAI-1, and TNFa, were mea-
sured simultaneously; but no signiﬁcant changes were observed.
Taken together, our results clearly indicated that MCFAs readily
intensiﬁed the TNFa-dependent down-regulation of adiponectin
mRNA expression level through binding with GPR84. It is interest-
ing that in the case of RAW264.7 cells, the pretreatment with LPS
was necessary to enhance IL-12 mRNA expression in them [5].
Presumably, the enrichment of GPR84 by inﬂammagens would be
required for both cell lines to C10 functions effectively.There is a question that medium-chain fatty acids (MCFAs)
present in the adipose tissue is sufﬁcient enough to stimulate the
MCFA–GPR84 system. Postprandial plasma levels of octanoic and
decanoic acids are below the lM range in humans having regular
Fig. 5. Down-regulation of adiponectin mRNA levels in 3T3-L1 adipocytes by
GPR84 ligands. Cells were preincubated with/without 10 ng/ml TNFa for 24 h,
followed by the incubation for 6 h with various concentrations of decanoic acid
(C10) (A) or undecanoic acid (C11, B). Data are shown as the mean ± S.E.M. (n = 4 for
each group), expressed as the value relative to that of the ligand-free control.
⁄p < 0.05, signiﬁcant difference vs. siFLUC control.
372 H. Nagasaki et al. / FEBS Letters 586 (2012) 368–372diet; however, a medium-chain triglyceride (MCT)-rich diet ele-
vates the C8 and C10 level as high as 10–50 lM in humans [15].
Therefore, it is possible that the MCFA level reaches the EC50 for
GPR84 binding after consumption of a MCT-rich diet.
On the other hand, previous reports indicated that MCT contain-
ing coconut or palm oil, or constituent of butter could help burning
excess calories, resulting in weight loss [16,17]. In the rat,
MCT-rich chow signiﬁcantly increased the plasma adiponectin le-
vel than did long-chain tryglyceride-rich chow [18]. These reports
indicating that a MCT-rich diet can enhance the adiponectin
expression in humans and in experimental animals are contrary
to our present data showing that MCFAs down-regulated adipo-
nectin mRNA expression level in 3T3-L1 adipocytes. However, this
discrepancy might be well resolved by supposing that the MCFA–
GPR84 system would effectively function when the adipose tissue
becomes inﬂamed due to the presence of TNFa generated by the
cross-talk between the adipocytes and macrophages that have
inﬁltrated into the adipose tissue.
Besides the ingested MCT, MCFA would possibly be produced
from the intrinsic metabolic pathways for synthesis and degrada-
tion, such as fatty acid synthesis in the cytosol and b-oxidation
of long-chain fatty acids in the mitochondria, respectively. Intrinsic
MCT or MCFA is utilized in the acyl modiﬁcation of ghrelin, that is
essential for its activity in growth hormone secretion [19–21]. Like
in the case of ghrelin octanoylation, not only MCFAs of dietary
origin but also the intrinsic ones could be released from the cell
into the circulation or in a paracrine fashion to stimulate GPR84
present in the cell membrane of adipocytes.
Based on the results obtained in this study, we propose for the
ﬁrst time the following scheme: that GPR84 mRNA expression is
enhanced in the adipocytes stimulated by macrophages that have
inﬁltrated into the adipose tissue, in which case the stimulator
playing this critical role is TNFa released from the macrophages.
MCFA such as C10 suppresses adiponectin mRNA expression inTNFa-primed adipocytes. Collectively, this MCFA–GPR84 system is
assignednot only abeneﬁcial role of burningexcess calories, but also
is a constituent of the vicious cycle between the adiposity and
diabetes.
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